Details for Patent: 11,717,571
✉ Email this page to a colleague
Which drugs does patent 11,717,571 protect, and when does it expire?
Patent 11,717,571 protects NEFFY and is included in one NDA.
This patent has seventy patent family members in twenty-eight countries.
Drugs Protected by US Patent 11,717,571
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,717,571
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009329952 | ⤷ Sign Up | |||
| Australia | 2011317202 | ⤷ Sign Up | |||
| Australia | 2019217643 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
